Our Most Well-Read Investor Relations Posts of 2016
After several years of extraordinary performance, healthcare stocks endured a challenging year in 2016. The Nasdaq Health Care and Biotechnology Indices were down almost 14 percent and more than 18 percent, respectively, year to date, through Dec. 12.
Whether you’re a leader of a public healthcare company, or a private company with plans for an IPO, carefully planned and flawlessly executed investor relations strategies are more important than ever during periods of increased scrutiny from Wall Street.
Only time will tell how 2017 plays out, but to help you prepare for whatever may lie ahead, we take a look back on our most widely read blog posts from 2016.
How to Write Your Annual Letter to Shareholders
By Peter Vozzo, Managing Director
The annual letter to shareholders is an important – and obligatory – task for all public companies. So we’re surprised by the number of companies we see that don’t take the responsibility as seriously as they should. Peter Vozzo has advice for getting your letter done.
Alternative to Typical Analyst Day
By John Woolford, Managing Director
An Investor Day is a great tool for communicating your message to Wall Street, but it’s a day-long event that takes months to plan and execute. Sometimes you need a simpler, less time-consuming format for communicating important information. Consider an Investor or Analyst Briefing instead. John Woolford explains the details
The Perfect Earnings Call: Your 5-Week Prep Plan
By Patti Bank, Managing Director
A single earnings call can affect the value of your stock, for better or worse – and there are plenty of things that can go wrong. Good preparation is the key to a flawless call, beginning well in advance of the call date. Patti Bank offers details on the five-week schedule we suggest our clients follow.
Non-Deal Road Shows: A Leading Investor’s Top 5 Tips
By Rob Leggat, Managing Director
Non-deal road shows offer a range of benefits for your company. But what are the investors themselves looking for from these meetings? Our Rob Leggat gets the answer from one of the most successful portfolio managers he’s ever met.
The IPO Window May Be Reopening: 5 Things to Do Now
By Chris Brinzey, Managing Director
Thanks to weak market conditions, it was nearly impossible to go public during the first half of 2016. Since then, however, circumstances have improved considerably for healthcare companies considering an IPO. Those that took Chris Brinzey’s advice in April about strengthening their hand while awaiting better conditions are glad they did.
Keep these lessons in mind as you prepare for the year ahead, and peruse the rest of our blog for more insights. For more detailed guidance on every aspect of the IR process, I urge you to download our new eBook, Westwicke Insider’s Guide to Investor Relations. And whether you’re still private or already public, feel free to reach out for a conversation about how to broaden your investor base, communicate with your investors more effectively, or develop an effective IR strategy.
Leave a Reply